Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled date : 2022 - 06 - 13 save search
FDA Approves First Systemic Treatment for Alopecia Areata
Published: 2022-06-13 (Crawled : 20:00) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
treatment fda
Global Cytotoxic Drugs Market Estimated to Reach $14,885.2 Million by 2028 and Grow at 1.2% CAGR in the 2021-2028 Timeframe [202-Pages] | Report by Research Dive
Published: 2022-06-13 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: -4.56%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -2.38%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
research report market
Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies
Published: 2022-06-13 (Crawled : 12:20) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
AKTX | $1.25 3.31% 3.2% 7.5K
|
Health Technology
|
| O: -0.99%
H: 3.0%
C: -1.1%
biotech therapeutics growth
IASO Bio and Innovent Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022
Published: 2022-06-13 (Crawled : 02:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
car-t therapy
Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022
Published: 2022-06-13 (Crawled : 01:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
ibi362 obesity chinese results phase 1
Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022
Published: 2022-06-13 (Crawled : 01:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
car-t therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.